David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $15.5M | 0.02% |
142,550
+103,564
| +266% | +$11.6M |
|
|
MGLN
1002
DELISTED
Magellan Health Services, Inc.
MGLN
| $15.5M | 0.02% |
166,456
-117,821
| -41% | -$11M |
|
|
DFS
1003
DELISTED
Discover Financial Services
DFS
| $15.5M | 0.02% |
163,274
+151,428
| +1,278% | +$14.3M |
|
1004
PUT
Ulta Beauty
ULTA
$23.2B
| $15.5M | 0.01% |
50,000
+19,000
| +61% | +$5.9M |
|
1005
Strategic Education
STRA
$1.87B
| $15.5M | 0.01% |
168,169
+19,528
| +13% | +$1.75M |
|
1006
Enphase Energy
ENPH
$4.91B
| $15.4M | 0.01% |
+95,214
| New | +$17.1M |
|
1007
PUT
Altria Group
MO
$114B
| $15.3M | 0.01% |
300,000
-377,800
| -56% | -$16.9M |
|
1008
Oceaneering
OII
$5.02B
| $15.3M | 0.01% |
1,343,541
-698,890
| -34% | -$7.75M |
|
1009
PUT
CRISPR Therapeutics
CRSP
$5.52B
| $15.3M | 0.01% |
+125,500
| New | +$19M |
|
1010
Apollo Global Management
APO
$78.4B
| $15.3M | 0.01% |
325,045
+302,515
| +1,343% | +$14.7M |
|
1011
PUT
Strategy Inc
MSTR
$48.7B
| $15.3M | 0.01% |
+225,000
| New | +$15.9M |
|
1012
CALL
JD.com
JD
$39.4B
| $15.2M | 0.01% |
180,700
-394,100
| -69% | -$36.1M |
|
|
JNPR
1013
DELISTED
Juniper Networks
JNPR
| $15.2M | 0.01% |
601,324
-1,325,344
| -69% | -$32.6M |
|
1014
Kinder Morgan
KMI
$69B
| $15.2M | 0.01% |
914,289
-4,459,393
| -83% | -$68.1M |
|
1015
PUT
United Parcel Service
UPS
$87.4B
| $15.2M | 0.01% |
89,500
-180,100
| -67% | -$29.1M |
|
1016
Howmet Aerospace
HWM
$105B
| $15.2M | 0.01% |
472,828
-3,072,065
| -87% | -$88.4M |
|
1017
Opko Health
OPK
$1.1B
| $15.2M | 0.01% |
3,535,631
+3,505,182
| +11,512% | +$16.7M |
|
1018
Tyson Foods
TSN
$20.4B
| $15.1M | 0.01% |
203,795
-108,927
| -35% | -$7.52M |
|
1019
Carlisle Companies
CSL
$14.4B
| $15.1M | 0.01% |
91,932
+8,258
| +10% | +$1.27M |
|
1020
PUT
Domino's
DPZ
$11.5B
| $15.1M | 0.01% |
41,100
+4,100
| +11% | +$1.51M |
|
1021
Pebblebrook Hotel Trust
PEB
$2.07B
| $15.1M | 0.01% |
622,261
-188,613
| -23% | -$4.14M |
|
1022
Liberty Global Class A
LBTYA
$3.66B
| $15.1M | 0.01% |
588,847
-208,445
| -26% | -$5.27M |
|
1023
Delek US
DK
$4.17B
| $15.1M | 0.01% |
691,308
+165,188
| +31% | +$3.61M |
|
1024
Palantir
PLTR
$423B
| $15.1M | 0.01% |
+646,416
| New | +$17.7M |
|
1025
Newell Brands
NWL
$2.59B
| $15M | 0.01% |
560,851
-189,093
| -25% | -$4.69M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.